FDA Approves First Rapid-Acting Insulin Biosimilar Product for ...
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and...
Insulin | FDA - U.S. Food and Drug Administration
My Insulin. Ask your healthcare provider these questions before you start using your insulin. How will my insulin affect my blood sugar? Will it affect my other medicines? What are the side...
100 Years of Insulin | FDA - U.S. Food and Drug Administration
To commemorate the 100th anniversary of the discovery of insulin, the FDA History Office provides the following overview of major milestones in the regulation of this life-saving drug.
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients …
5 days ago · HealthDay News — The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.. Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA. Administering Merilog subcutaneously five to 10 minutes before mealtime ...
FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog
February 14, 2025 -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to NovoLog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.
FDA Approves First Rapid-Acting Insulin Biosimilar Product for ...
SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for ...
Feb 20, 2025 · Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA. Administering Merilog subcutaneously five to 10 minutes before mealtime helps improve glycemic control in patients with diabetes.
FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes
Feb 19, 2025 · The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
List of commercially available insulins - Wikipedia
Insulin lispro, marketed under the brand name Humalog among others, is a modified form of medical insulin used to ... In July 2021, the US Food and Drug Administration (FDA) approved an interchangeable biosimilar insulin product, Semglee (insulin glargine-yfgn), for the treatment of diabetes. [14] Unbranded versions of insulin glargine and ...
First interchangeable biosimilar insulin product approved by …
Jul 28, 2021 · Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with...